Gene · 28882
Papers3,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of biophysical stimulation in multimodal management of vertebral compression fractures. | Comput Struct Biotechnol J | 2023 | 38047233 | PubTator, text mining | PubMed |
| Molecular characteristics of circulating B cells and kidney cells at the single-cell level in special types of primary membranous nephropathy. | Clin Kidney J | 2023 | 38046035 | PubTator, text mining | PubMed |
| Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes. | Neuropsychiatr Dis Treat | 2023 | 38029048 | PubTator, text mining | PubMed |
| A2BR facilitates the pathogenesis of H. pylori-associated GU by inducing oxidative stress through p38 MAPK phosphorylation. | Heliyon | 2023 | 38027590 | PubTator, text mining | PubMed |
| Analysis of ADORA2A, MTA1, PTGDS, PTGS2, NSF, and HNMT Gene Expression Levels in Peripheral Blood of Patients with Early Stages of Parkinson's Disease. | Biomed Res Int | 2023 | 38027039 | PubTator, text mining | PubMed |
| Adenosine, bridging chronic inflammation and tumor growth. | Front Immunol | 2023 | 38022572 | PubTator, text mining | PubMed |
| Case report: Diagnosis of ADCY5-related dyskinesia explaining the entire phenotype in a patient with atypical citrullinemia type I. | Front Neurol | 2023 | 38020658 | PubTator, text mining | PubMed |
| Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide. | Molecules | 2023 | 38005269 | PubTator, text mining | PubMed |
| Dynamic CT Myocardial Perfusion: The Role of Functional Evaluation in the Diagnosis of Coronary Artery Disease. | J Clin Med | 2023 | 38002675 | PubTator, text mining | PubMed |
| Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors. | Biomolecules | 2023 | 38002292 | PubTator, text mining | PubMed |
| Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design. | Bioinformatics | 2023 | 37971970 | PubTator, text mining | PubMed |
| Reinforcement Learning Algorithms for Autonomous Mission Accomplishment by Unmanned Aerial Vehicles: A Comparative View with DQN, SARSA and A2C. | Sensors (Basel) | 2023 | 37960711 | PubTator, text mining | PubMed |
| The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives. | Mil Med Res | 2023 | 37936201 | PubTator, text mining | PubMed |
| Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failure. | Front Cardiovasc Med | 2023 | 37920183 | PubTator, text mining | PubMed |
| The shared genetic risk factors between Tourette syndrome and obsessive-compulsive disorder. | Front Neurol | 2023 | 37905190 | PubTator, text mining | PubMed |
| Loss of adenosine A3 receptors accelerates skeletal muscle regeneration in mice following cardiotoxin-induced injury. | Cell Death Dis | 2023 | 37898628 | PubTator, text mining | PubMed |
| Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy. | Pharmaceutics | 2023 | 37896201 | PubTator, text mining | PubMed |
| Modulation of Neuron and Astrocyte Dopamine Receptors via Receptor-Receptor Interactions. | Pharmaceuticals (Basel) | 2023 | 37895898 | PubTator, text mining | PubMed |
| Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade. | BMC Complement Med Ther | 2023 | 37891562 | PubTator, text mining | PubMed |
| Cardiorespiratory and Neuroprotective Effects of Caffeine in Neonate Animal Models. | Animals (Basel) | 2023 | 37889643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28882/papers?page=8